Terray Therapeutics
-
Business & Markets · Startups Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic
Insider Brief Terray Therapeutics has raised $120 million in Series B funding, led by Bedford Ridge Capital and NVentures (NVIDIA’s venture arm), to advance its small molecule drug development programs into clinical trials and… -
Technology & Infrastructure · Data centres & compute Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.